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Background
Systemic sclerosis (SSc) is an autoimmune disease char-
acterized by vasculopathy, immune cell activation and
fibrosis of the skin and internal organs, occurring mainly
in females. Although a lot of progress has been made in
the discovery of genetic risk factors for SSc, environmen-
tal factors triggering onset of SSc have not been identi-
fied. This provides a foundation for the involvement of
processes related to biological ageing to trigger SSc onset
and perpetuation in the genetically susceptible host. Con-
sequently, we have investigated key determinants of bio-
logical ageing, namely telomere attrition and the role of
telosome proteins in the pathology of systemic sclerosis
and how it impacts on individual leukocyte cell subsets.
Epigenetic processes, such as telomere attrition have
been implicated in SSc [1]. The length of telomeric DNA
repeats shortens during replicative ageing of peripheral
blood lymphocytes. This process is exacerbated by psycho-
logical, sociological and biological determinants [2,3]. As a
consequence, telomere length reflects the “miles on the
clock” of a given cell type. Proteinaceous components of
the associatedtelosome arecomplicit in the sensing, signal-
ing and repair of DNA damage [3]. These have a critical
role inprotectingthe cell from excessive DNA damage, by
facilitating cellular senescence and apoptosis.
This study aimed to evaluate telosome biologyin an
independent, clinically well-defined SSc cohorts. More-
over, we aimed to investigate whether there are differences
in telomere attrition between different immune cell sub-
sets and if these differences are accompanied by changes
in expression of genes involved in telomere functioning.
Materials and methods
Telomere lengths were determine by Q-PCR [4] and
telosome transcript expression levels measured by
RT-PCR [4].Statistical analyses were undertaken to
investigate the association between telomere lengths,
telosome transcript levels and clinico-pathological
features of the disease, in peripheral blood leukocytes
individual leukocyte subsets.
Results
We observed significant telomere attrition with increasing
chronological age in a control population (p<0.009; n=
382) but not in dcSSc samples from independent Dutch
(n=143) and UK cohorts (n=160). Despite this, dcSSc telo-
mere lengths were on average shorter than controls at any
given chronological age, reflecting more miles on the
clock with the disease state. We also observed dcSSc speci-
fic telomere shortening in pDCs (p=0.001) compared to
controls. This shortening was not further accelerated with
increasing chronological age.
Analysis of the telosome, indicated significant expression
changes in six key proteins relating to DNA repair and
telosome stability and regulation (p<0.01).
Conclusions
We have demonstrated that dcSSc exhibits features consis-
tent with accelerated biological ageing. This process
appears to be independent of increasing chronological age,
indicative of aberrant telosome biology with disease pre-
empting the development of clinical symptoms at a later
chronological date. Our data have provided novel insight
into the pathogenesis of dcSSC and identified new targets
for therapeutic intervention. They have also confirmed
pDCs as an important cell type in dcSSc pathogenesis.
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